trial or observed group · 2015
“In this large, cross-sectional study of middle-aged adults, we observed a significant dose-response relationship between SSB and fatty liver disease, with a 56% increased risk of fatty liver disease in daily consumers of SSB compared to non-SSB consumers.”
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. J Hepatol
Who: Middle-aged, mostly Caucasian adults from the Framingham Offspring and Third Generation cohorts (men >=35, non-pregnant women >40 for CT; high alcohol consumers excluded)
PMID 26055949
pooled analysis · 2019
“The pooled RR of NAFLD in individuals consuming sugar-sweetened beverages was 1.39 (95% CI, 1.29–1.50).”
Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis. Int J Environ Res Public Health
Who: 12 observational studies (9 cross-sectional, 2 case-control, 1 cohort) from China, USA, Germany, Australia and Israel; mostly adults, some adolescent and child samples
PMID 31234281
trial or observed group · 2022
“Higher average SSB intake is associated with increase in liver fat over 6 years of follow-up and increased odds of incident NAFLD especially among the older cohort, whereas no consistent association was observed for the younger Third Generation cohort.”
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study. Clin Gastroenterol Hepatol
Who: Framingham Heart Study Offspring (mean age 62.8) and Third Generation (mean age 48.4) participants with repeat CT scans, high alcohol consumers excluded; primarily white, non-Hispanic
PMID 34752964
other primary study · 2021
“These findings demonstrate that compared with aspartame-SB, the consumption of HFCS- or sucrose-SB at 25% Ereq for 2 weeks increased hepatic lipid content and decreased insulin sensitivity in healthy young adults, but there were no differences between effects of the 2 different sugars.”
Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults. J Clin Endocrinol Metab
Who: Healthy young adults aged 18-40 with BMI 18-35 kg/m2, no diabetes or liver disease, non-randomized groups matched for sex, BMI and lipids
PMID 34265055
other primary study · 2023
“Compared with non-SSB consumers, individuals who had ≥72 (male) and 50 (female) grams of sugar intake from total SSBs had a significantly higher risk of having NAFLD (aOR = 1.60, 95% CI = 1.05–2.45), after adjusting for demographic factors, risk behaviors, and BMI (Model 3).”
Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Nutrients
Who: Nationally representative US adults over 20 from NHANES 2017-March 2020 with transient elastography and two 24 h dietary recalls; heavy drinkers and known liver disease excluded
PMID 37764782